November 3, 2025 — Inspire Medical Systems, Inc. (NYSE: INSP) today released its financial results for the third quarter ended …
BreakingEarnings
-
-
November 3, 2025 — Leads & Copy — Hologic, Inc. (Nasdaq: HOLX) reported its fiscal fourth-quarter results, with revenue up …
-
BreakingFinancings
Kura Oncology (Nasdaq:KURA) Receives $30 Million Milestone Payment for Ziftomenib Trial
November 3, 2025 – San Diego, CA — Leads & Copy — Kura Oncology, Inc. (Nasdaq: KURA) has received a …
-
November 3, 2025 — Leads & Copy — Align Technology, Inc. (NASDAQ: ALGN) has announced the opening of its 2026 …
-
BreakingEarnings
Vertex Pharmaceuticals (Nasdaq:VRTX) Reports Strong Q3 2025 Results and Refines Guidance
November 3, 2025 — Leads & Copy — Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) reported strong third-quarter results, with total revenue …
-
BreakingEarnings
FibroGen (NASDAQ:FGEN) to Announce Q3 2025 Financial Results and Host Conference Call
SAN FRANCISCO, Nov. 3, 2025 — Leads & Copy — FibroGen, Inc. (NASDAQ: FGEN) will announce its third-quarter 2025 financial …
-
Nashville, Tenn. — November 3, 2025 — Leads & Copy — Insight Molecular Diagnostics Inc. (Nasdaq: IMDX) will report its …
-
BreakingR&D - Therapy
Solid Biosciences (Nasdaq:SLDB) Announces Positive Interim Data From INSPIRE DUCHENNE Trial
CHARLESTOWN, MA — November 3, 2025 — Leads & Copy — Solid Biosciences Inc. (Nasdaq: SLDB) reported financial results for …
-
TARRYTOWN, N.Y. — November 3, 2025 — Leads & Copy — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation …
-
CAMBRIDGE, Mass. — November 3, 2025 — Leads & Copy — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC) will present new data …